GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DT&CRO Co Ltd (XKRX:383930) » Definitions » Research & Development

DT&CRO Co (XKRX:383930) Research & Development : ₩0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is DT&CRO Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. DT&CRO Co's Research & Development for the three months ended in Mar. 2024 was ₩0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was ₩0 Mil.


DT&CRO Co Research & Development Historical Data

The historical data trend for DT&CRO Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DT&CRO Co Research & Development Chart

DT&CRO Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Research & Development
- - - -

DT&CRO Co Quarterly Data
Jun21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

DT&CRO Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DT&CRO Co  (XKRX:383930) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


DT&CRO Co Research & Development Related Terms

Thank you for viewing the detailed overview of DT&CRO Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


DT&CRO Co (XKRX:383930) Business Description

Traded in Other Exchanges
N/A
Address
28, Baengnyeong-ro 20beon-gil, 2nd, 3rd, 4th floor, Na-dong, Cheoin-gu, Gyeonggi-do (Yubang-dong), Yongin-si, KOR, 17042
DT&CRO Co Ltd conducts a series of consigned research, from non-clinical GLP toxicity, PK, and efficacy tests required for licensing of pharmaceuticals, chemicals, health functional foods, cosmetics and medical devices, to analysis, bioactivity, clinical trials, and licensing consulting. provided as a service.

DT&CRO Co (XKRX:383930) Headlines

No Headlines